Yamauchi Chikako, Mitsumori Michihide, Nagata Yasushi, Kokubo Masaki, Inamoto Takashi, Mise Keiichi, Kodama Hiroshi, Hiraoka Masahiro
Department of Therapeutic Radiology and Oncology Graduate School of Medicine, Kyoto University 54 Kawahara-cho, Shogoin, Sakyo, Kyoto, 606-8507, Japan.
Breast Cancer. 2005;12(2):135-9. doi: 10.2325/jbcs.12.135.
Although breast-conserving surgery followed by definitive irradiation is an established treatment for patients with early breast cancer, the role of breast-conserving therapy (BCT) for patients with bilateral breast cancer has not been well studied and the radiation therapy technique is still under investigation. We examined the feasibility of breast-conserving therapy for bilateral breast cancer and present here our radiation therapy technique with CT simulator.
Between July 1990 and December 1998, we treated 17 patients with bilateral breast cancer who underwent bilateral breast-conserving surgery followed by definitive irradiation. Seven patients had synchronous bilateral breast cancer and ten had metachronous bilateral breast cancer. Radiation therapy consisted of 50 Gy to the bilateral whole breast in all patients but one. A CT simulator was used to plan a tangential radiation field to the breast in all patients. Boost irradiation of 10 Gy was administered to 8 tumors with close or positive margins.
With a median follow-up periods of 95 months from each operation, no patients showed loco-regional recurrence on either side, and none suffered distant metastasis. Furthermore no serious late adverse effects were observed.
This study demonstrated that BCT is feasible for bilateral breast cancer and the CT simulator is useful for determining the radiation field, especially when lesions are metachronous.
尽管保乳手术联合根治性放疗是早期乳腺癌患者的既定治疗方法,但保乳治疗(BCT)对双侧乳腺癌患者的作用尚未得到充分研究,放疗技术仍在研究中。我们研究了双侧乳腺癌保乳治疗的可行性,并在此介绍我们使用CT模拟机的放疗技术。
1990年7月至1998年12月期间,我们治疗了17例双侧乳腺癌患者,这些患者均接受了双侧保乳手术并随后进行了根治性放疗。7例为同步双侧乳腺癌,10例为异时双侧乳腺癌。除1例患者外,所有患者双侧全乳放疗剂量均为50 Gy。所有患者均使用CT模拟机规划乳腺的切线照射野。对8例切缘接近或阳性的肿瘤给予10 Gy的追加照射。
每次手术后的中位随访期为95个月,两侧均未出现局部区域复发,也无远处转移。此外,未观察到严重的晚期不良反应。
本研究表明,BCT对双侧乳腺癌是可行的,CT模拟机有助于确定放疗野,尤其是在病变为异时性时。